Fox Run Management »

Monte Rosa Therapeutics shares owned by Fox Run Management

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Fox Run Management from 13F filings

Historical chart of Fox Run Management investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Fox Run Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Fox Run Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $360k 15k 24.20
2025-03-31 $127k 27k 4.64

More positions owned by Fox Run Management

Select Sector Spdr Tr St Str Finl Etf (XLF)
Burlington Stores (BURL)
IDEXX Laboratories (IDXX)
Oracle Corporation (ORCL)
Spx Corp (SPXC)
Globalfoundries Ordinary Shares (GFS)
Uber Technologies (UBER)
Synopsys (SNPS)
Vistra Energy (VST)
Intercontinental Exchange (ICE)
Pentair SHS (PNR)
Lauder Estee Cos Cl A (EL)
Thermo Fisher Scientific (TMO)
Ferguson Enterprises Common Stock New (FERG)
Guardant Health (GH)

View all positions for Fox Run Management

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BlackRock
T. Rowe Price Associates
TCG Crossover Management
Vestal Point Capital
BVF
Baker Bros. Advisors
Suvretta Capital Management
Vanguard Capital Management
State Street Corporation
Versant Venture Management
Braidwell
Geode Capital Management
American Century Companies
Marshall Wace

View all funds holding Monte Rosa Therapeutics